Cargando…

Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient Blood

[Image: see text] Circulating tumor cells (CTCs) and exosomes, both released from the primary tumor into peripheral blood, are a promising source of cancer biomarkers. They are detectable in the blood and carry a large diversity of biological molecules, which can be used for the diagnosis and monito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jianhui, Tan, Zhijing, Zhang, Jie, An, Mingrui, Khaykin, Valerie M., Cuneo, Kyle C., Parikh, Neehar D., Lubman, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609053/ https://www.ncbi.nlm.nih.gov/pubmed/36312392 http://dx.doi.org/10.1021/acsomega.2c04428

Ejemplares similares

A Method for Isolation and Proteomic Analysis of Outer Membrane Vesicles from Fecal Samples by LC-MS/MS
por: Wu, Jing, et al.
Publicado: (2019)

CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias
por: Pei, Xiucong, et al.
Publicado: (2016)

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer
por: Yang, Rui, et al.
Publicado: (2016)

Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023)

Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples
por: Gogoi, Priya, et al.
Publicado: (2016)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

Large Scale Screening and Quantitative Analysis of Site-Specific N-Glycopeptides from Human Serum in Early Alzheimer’s Disease Using LC-HCD-PRM-MS
por: Pan, Lingyun, et al.
Publicado: (2022)

Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients
por: Francescangeli, Federica, et al.
Publicado: (2021)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements
por: Kallergi, G., et al.
Publicado: (2018)

Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022)

Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice
por: Hamza, Bashar, et al.
Publicado: (2021)

Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma
por: Zhu, Jianhui, et al.
Publicado: (2017)

Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients
por: Pirie-Shepherd, Steven R., et al.
Publicado: (2017)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)

PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)

ERBB signaling in CTCs of ovarian cancer and glioblastoma
por: Geethadevi, Anjali, et al.
Publicado: (2017)

CTCs 2020: Great Expectations or Unreasonable Dreams
por: Rossi, Elisabetta, et al.
Publicado: (2019)

The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course
por: Taddei, A., et al.
Publicado: (2015)

Design of a Hybrid Inertial and Magnetophoretic Microfluidic Device for CTCs Separation from Blood
por: Nasiri, Rohollah, et al.
Publicado: (2021)

Molecular characterization of breast cancer CTCs associated with brain metastasis
por: Boral, Debasish, et al.
Publicado: (2017)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

Potential Use of CTCs as Biomarkers in Renal Cancer Patients
por: Bialek, Joanna, et al.
Publicado: (2022)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
por: Keup, Corinna, et al.
Publicado: (2022)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2016)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Pure CTCs, advanced WGS, and precise personalized combination therapies
por: Peters, Brock A., et al.
Publicado: (2017)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Mass-Selected Site-Specific Core-Fucosylation of Ceruloplasmin in Alcohol-Related Hepatocellular Carcinoma
por: Yin, Haidi, et al.
Publicado: (2014)

The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2023)

Detection of circulating tumor cells (CTCs) in cerebrospinal fluid of a patient with HER2-overexpressing gastric cancer and single cell analysis of intra-patient heterogeneity of CTCs
por: Cho, Jang Ho, et al.
Publicado: (2019)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
por: Zhang, Zhuo, et al.
Publicado: (2015)

CtcS, a MarR family regulator, regulates chlortetracycline biosynthesis
por: Kong, Lingxin, et al.
Publicado: (2019)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
por: Mathias, Trevor J., et al.
Publicado: (2020)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
por: Nel, Ivonne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34hgi2clb7emo4er8ji846vcvl